Search Orphan Drug Designations and Approvals
-
Generic Name: | ivabradine |
---|---|
Date Designated: | 07/09/2018 |
Orphan Designation: | Treatment of post-cardiac transplant heart dysfunction |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 07/22/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amgen, Inc., 1 Amgen Center Drive Mail Stop 27-2-D Thousand Oaks, California 91320 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-